These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1421173)
1. A high frequency of N-RAS oncogene mutations in multiple myeloma. Tanaka K; Takechi M; Asaoku H; Dohy H; Kamada N Int J Hematol; 1992 Oct; 56(2):119-27. PubMed ID: 1421173 [TBL] [Abstract][Full Text] [Related]
2. Oncogenes in multiple myeloma: point mutation of N-ras. Paquette RL; Berenson J; Lichtenstein A; McCormick F; Koeffler HP Oncogene; 1990 Nov; 5(11):1659-63. PubMed ID: 2267133 [TBL] [Abstract][Full Text] [Related]
3. RAS gene mutations in multiple myeloma and related monoclonal gammopathies. Matozaki S; Nakagawa T; Nakao Y; Fujita T Kobe J Med Sci; 1991 Feb; 37(1):35-45. PubMed ID: 1921261 [TBL] [Abstract][Full Text] [Related]
4. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602 [TBL] [Abstract][Full Text] [Related]
6. Mutations in ras oncogenes: rare events in ultraviolet B radiation-induced mouse skin tumorigenesis. Khan SG; Mohan RR; Katiyar SK; Wood GS; Bickers DR; Mukhtar H; Agarwal R Mol Carcinog; 1996 Feb; 15(2):96-103. PubMed ID: 8599584 [TBL] [Abstract][Full Text] [Related]
7. RAS mutations are uncommon in multiple myeloma and other monoclonal gammopathies. Martín P; Santón A; García-Cosío M; Bellas C Int J Oncol; 2005 Oct; 27(4):1023-8. PubMed ID: 16142319 [TBL] [Abstract][Full Text] [Related]
8. p53 and RAS gene mutations in multiple myeloma. Portier M; Molès JP; Mazars GR; Jeanteur P; Bataille R; Klein B; Theillet C Oncogene; 1992 Dec; 7(12):2539-43. PubMed ID: 1461658 [TBL] [Abstract][Full Text] [Related]
9. Absence of N-ras mutations in myeloid and lymphoid blast crisis of chronic myeloid leukemia. Watzinger F; Gaiger A; Karlic H; Becher R; Pillwein K; Lion T Cancer Res; 1994 Jul; 54(14):3934-8. PubMed ID: 8033117 [TBL] [Abstract][Full Text] [Related]
10. Activation of K-ras by codon 13 mutations in C57BL/6 X C3H F1 mouse tumors induced by exposure to 1,3-butadiene. Goodrow T; Reynolds S; Maronpot R; Anderson M Cancer Res; 1990 Aug; 50(15):4818-23. PubMed ID: 2196119 [TBL] [Abstract][Full Text] [Related]
11. Sporadic and Thorotrast-induced angiosarcomas of the liver manifest frequent and multiple point mutations in K-ras-2. Przygodzki RM; Finkelstein SD; Keohavong P; Zhu D; Bakker A; Swalsky PA; Soini Y; Ishak KG; Bennett WP Lab Invest; 1997 Jan; 76(1):153-9. PubMed ID: 9010458 [TBL] [Abstract][Full Text] [Related]
12. K-ras activation in premalignant and malignant epithelial lesions of the human uterus. Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654 [TBL] [Abstract][Full Text] [Related]
13. Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Levi S; Urbano-Ispizua A; Gill R; Thomas DM; Gilbertson J; Foster C; Marshall CJ Cancer Res; 1991 Jul; 51(13):3497-502. PubMed ID: 1675933 [TBL] [Abstract][Full Text] [Related]
14. Activation of protooncogenes in spontaneously occurring non-liver tumors from C57BL/6 x C3H F1 mice. Candrian U; You M; Goodrow T; Maronpot RR; Reynolds SH; Anderson MW Cancer Res; 1991 Feb; 51(4):1148-53. PubMed ID: 1997158 [TBL] [Abstract][Full Text] [Related]
15. Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6. Billadeau D; Jelinek DF; Shah N; LeBien TW; Van Ness B Cancer Res; 1995 Aug; 55(16):3640-6. PubMed ID: 7627974 [TBL] [Abstract][Full Text] [Related]
16. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing. Tada M; Omata M; Ohto M Cancer Res; 1990 Feb; 50(4):1121-4. PubMed ID: 2153451 [TBL] [Abstract][Full Text] [Related]
17. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features. Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347 [TBL] [Abstract][Full Text] [Related]
19. High incidence of N and K-Ras activating mutations in multiple myeloma and primary plasma cell leukemia at diagnosis. Bezieau S; Devilder MC; Avet-Loiseau H; Mellerin MP; Puthier D; Pennarun E; Rapp MJ; Harousseau JL; Moisan JP; Bataille R Hum Mutat; 2001 Sep; 18(3):212-24. PubMed ID: 11524732 [TBL] [Abstract][Full Text] [Related]
20. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]